Skip to main content
OpenTrials
Completed

NCT Number: NCT05087550

Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation

Organ procurement organizations (OPO) have increased organ recovery efficiency and yield and have also reduced organ acquisition charges. The new liver allocation policy came into effect in February 2020 and aims to increase access to organs for waitlist candidates with the greatest severity of illness. The urgent change was driven by the perception that patients were dying because of arbitrary boundaries and inequitable access. Critics of the new policy have highlighted the potential cost implications particularly at an OPO level. A study of five OPOs throughout the United States highlighted an increase in costs ranging from 43% - 206% despite the same volume of livers transplanted. The main reason for the cost appears to lie in organ handling and transport. This mirrors the findings of Puri and colleagues who acknowledged changes to lung transplantation at Barnes Jewish Hospital in the pre- and post-policy eras and reported a substantial decline in local donors. The new lung system has also resulted in a higher organ discard rate and ultimately higher costs. Such data has generated meaningful discussions regarding optimizing organ allocation polices, however, data from individual transplant centers is lacking in the literature. Changes at a transplant center level relating to recipient costs are likely impacted by the new policy, which could be related to patient travel, accommodation, work up etc.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The Liver Institute at Methodist Dallas Medical Center

Dallas, Texas, 75203, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Underwent liver transplantation at MDMC between February 4th 2019 - February 4th 2020 and February 5th 2020 - February 5th 2021

Exclusion criteria

  • Below 18 years of age
  • Did not undergo liver transplantation

Treatment and study plan

Liver Transplantation

Procedure

Patients who underwent liver transplantation at Methodist Dallas Medical Center

Primary outcomes

  1. Liver transplant volume

    Time frame: 02/04/2019 - 02/05/2021

  2. Cost

    Time frame: 02/04/2019 - 02/05/2021

    Costs related to:

    • Transplant volume and organ recovery information
    • Transportation costs, distance traveled, travel time
    • Personnel costs
    • Hospital charges/costs

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Collaborators

  • Washington University School of Medicine

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Oct 21, 2021
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.